CDC Recommendations for Nirsevimab Shortage
The US CDC has issued advice for healthcare providers to navigate the shortage of nirsevimab (Beyfortus), used to immunize infants from RSV.
Tag: Sanofi
All
Latest
All
Latest
Sanofi-GSK Vaccine 100% Effective in Preventing Against Severe COVID-19, Hospitalizations
Sanofi and GSK will submit data from both their booster and Phase 3 efficacy trials to the FDA and other international regulatory agencies for authorization of their Sanofi-GSK COVID-19 vaccine.
